Thursday, October 17, 2024
No menu items!
HomeLonza to buy back $2.17 billion worth of shares, backs mid-term growthFILE PHOTO: Logo of Swiss contract drug maker Lonza is

FILE PHOTO: Logo of Swiss contract drug maker Lonza is

FILE PHOTO: The logo of Swiss contract drug maker Lonza is seen at its headquarters in Basel, Switzerland October 1, 2020. REUTERS/Arnd Wiegmann/File Photo
FILE PHOTO: A logo is pictured on the Ibex building
- Advertisment -

Most Read

© Newspaper WordPress Theme by TagDiv